Grace Therapeutics, Inc. Liquidation Value
GRCE
Other
Cash & Equivalents
$18.67M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $18.67M
Total Obligations: -$1.28M
$17.39M
Per share: $1.12
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $18.67M
AR: $0
Total Obligations: -$1.28M
$17.39M
Per share: $1.12
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $18.67M
AR: $0
Inventory: $0
Total Obligations: -$1.28M
$17.39M
Per share: $1.12
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $17.39M | $1.12 |
| Liquid Liquidation Value | $17.39M | $1.12 |
| Operating Liquidation Value | $17.39M | $1.12 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $18.67M |
| Accounts Receivable | $20,000 |
| Inventory | N/A |
| Current Liabilities | $1.28M |
| Long-term Debt | N/A |
| Op. Lease Liability | $0 |
| Finance Lease | N/A |
| Shares Outstanding | 15.5M |
Explore all 71 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $18.67M | N/A | N/A | N/A | $1.28M | N/A | N/A | N/A |
| 2025-09-30 | $16.86M | N/A | N/A | N/A | $1.25M | N/A | N/A | N/A |
| 2025-06-30 | $20.00M | $20,000 | N/A | N/A | $2.31M | N/A | N/A | N/A |
| 2025-03-31 | $22.13M | $20,000 | N/A | N/A | $1.93M | N/A | N/A | N/A |
| 2024-12-31 | $11.05M | $20,000 | N/A | N/A | $1.97M | N/A | N/A | N/A |
| 2024-09-30 | $15.15M | $20,000 | N/A | N/A | $2.67M | N/A | N/A | N/A |
| 2024-06-30 | $19.39M | $398,000 | N/A | N/A | $2.60M | N/A | N/A | N/A |
| 2024-03-31 | $23.00M | $722,000 | N/A | N/A | $1.68M | N/A | $0 | N/A |
▼ Community Notes